SKIN Insider Trading Activity and SEC Form 4 Filings
SKIN insider trading summary
No open-market insider purchases or sales of Beauty Health Co (SKIN) have been reported on SEC Form 4 in the past 12 months.
Latest SKIN insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Nov 20, 2024 | Desiree Gruber | Director | Sell | $22K (14,663 @ $1.50) |
| Aug 12, 2024 | Brent L Saunders | Director | Buy | $44K (40,450 @ $1.08) |
| Aug 17, 2023 | Brian Christopher Miller | Director | Buy | $349K (60,000 @ $5.81) |
| Aug 17, 2023 | Michael D Capellas | Director | Buy | $181K (30,000 @ $6.03) |
| Aug 17, 2023 | Andrew Roy Stanleick | Chief Executive Officer | Buy | $100K (16,485 @ $6.05) |
| Aug 17, 2023 | Michael P. Monahan | Chief Financial Officer | Buy | $30K (5,000 @ $6.02) |
| Aug 16, 2023 | Brent L Saunders | Director | Buy | $362K (59,380 @ $6.10) |
| Aug 16, 2023 | Doug K. Schillinger | Director | Buy | $202K (33,000 @ $6.11) |
| Aug 16, 2023 | Julius Few | Director | Buy | $125K (20,454 @ $6.10) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.